ropilynz xl 4 mg prolonged-release tablets
lupin (europe) limited - ropinirole - prolonged-release tablet - 4mg - dopamine agonists - treatment of parkinson's disease under the following conditions: initial treatment as monotherapy, in order to delay the introduction of levodopa in combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).
ropilynz xl 8 mg prolonged-release tablets
lupin (europe) limited - ropinirole - prolonged-release tablet - 8mg - dopamine agonists - treatment of parkinson's disease under the following conditions: initial treatment as monotherapy, in order to delay the introduction of levodopa in combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (“end of dose” or “on-off” type fluctuations).
sailexin salinomycin premix (granule) 12% ww
age d`or sdn. bhd. - salinomycin sodium -
crusia 2000 iu (20 mg)0.2 ml solution for injection in pre-filled syringe
unimed sdn bhd - enoxaparin sodium -
crusia 4000 iu (40 mg)0.4 ml solution for injection in pre-filled syringe
unimed sdn bhd - enoxaparin sodium -
crusia 6000 iu (60 mg)0.6 ml solution for injection in pre-filled syringe
unimed sdn bhd - enoxaparin sodium -
crusia 8000 iu (80 mg)0.8 ml solution for injection in pre-filled syringe
unimed sdn bhd - enoxaparin sodium -
cidofovir tillomed 75 mg/ml konzentrat zur herstellung einer infusionslösung
zoledronsäure sun 5 mg infusionslösung
duloxetin aurobindo 20 mg magensaftresistente hartkapseln